Achillion to Present at the JMP Securities Life Sciences Conference


You May Also Like

VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market

TEL AVIV, Israel, June 26, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology ...

Celsion Corporation Reports Second Quarter 2017 Financial Results and Provides Business Update

LAWRENCEVILLE, N.J., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...